Pharma Marketing Network

JUNE 14, 2025

But with hundreds of shows available, which ones stand out in 2025? Imagine being able to stay current on biotech breakthroughs, FDA approvals, and digital health trends—all while commuting or walking your dog. In this article, we spotlight the most influential pharma podcasts of 2025 and explain why they’re worth tuning into.

Communication 52

Communication FDA Packaging Labelling 52

Pharma Marketing Network

APRIL 2, 2025

In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability. In 2025, the ability to react to these preferences in near real time is what separates leading pharma marketing teams from the rest. FAQs What is the biggest trend in marketing in pharma in 2025?

Communication 64

Communication FDA 64

Pharma Marketing Network

DECEMBER 4, 2024

As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. Companies are investing heavily in digital tools to streamline communication and build stronger connections. Patient-Centric Marketing Patients want to feel heard. Patient-Centric Marketing Patients want to feel heard.

Communication 52

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

APRIL 28, 2025

Pharma marketing innovation is poised for an unprecedented surge in 2025, driven by new technologies, regulatory shifts, and evolving patient expectations. This article dives deep into why 2025 will mark a pivotal moment for pharma marketing and how savvy brands can stay ahead.

Communication 59

Communication Pharmaceutical Companies Pharmaceutical Companies FDA 59

PharmD Live

JUNE 23, 2025

This 2025 vendor landscape review highlights how PharmD Live stands out by combining pharmacist-led clinical expertise, AI-powered insights, and fully CMS-aligned virtual care services, delivering tangible, reportable results across complex patient populations. We show you the why and what to do about it before the patient deteriorates.

HIPAA 52

HIPAA Documentation Hospitals FDA 52

Pharma Marketing Network

JUNE 11, 2025

In 2025, the pace of change is faster than ever, driven by innovations in digital technology, new regulatory landscapes, and shifting expectations among healthcare providers and patients alike. Medical affairs teams now collaborate closely with marketing departments to ensure scientific accuracy in communications.

Communication 89

Communication HIPAA FDA 89

The FDA Law Blog

FEBRUARY 26, 2025

Claud The ongoing DOGE-led reductions to the federal workforce and recent sweeping policy changes have spawned many questions for compliance officers and quality managers in FDA-regulated companies. How will the cuts at FDA impact inspections and enforcement? Clarity of purpose is a good place to start. Dialogue is also key.

Communication 66

Communication FDA 66

The FDA Law Blog

APRIL 13, 2025

By Sarah Wicks & Dara Katcher Levy FDAs Office of Prescription Drug Promotion (OPDP) issued its second Untitled Letter of 2025 to Taiho Oncology (Taiho) for a healthcare provider branded website for its drug LYTGOBI (futibatinib). FDA did not object to the timing of the respective submissions in either letter.

FDA 52

FDA Communication 52

Pharmaceutical Technology

JUNE 25, 2025

June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.

FDA 52

FDA Packaging Communication Hospitals 52

PharmTech

JUNE 19, 2025

Communication between the manufacturing plant and retail stores. Image Credit: © Cagkan - © Cagkan - stock.adobe.com BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. June 17, 2025. Pharmaceutical Technology 2025 49 (4). Press Release. Haigney, S.

Dosage 59

Dosage Packaging FDA Communication 59

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight.

FDA 52

FDA Research Laboratories Communication Hospitals 52

Pharma Marketing Network

MAY 1, 2025

As we navigate through 2025, several key developments are reshaping the industry, from technological advancements to regulatory reforms. Regulatory Changes and Compliance Regulatory landscapes are shifting, with authorities like the FDA implementing new guidelines to ensure transparency and patient safety.

Communication 52

Communication FDA Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. Credit: Volha_R/Shutterstock.

FDA 52

FDA Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 9, 2025

June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook YOLT-101 will be a new treatment possibility for familial hypercholesterolemia. June 9, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook YOLT-101 will be a new treatment possibility for familial hypercholesterolemia.

FDA 52

FDA Communication Hospitals Packaging 52

Pharma Marketing Network

JUNE 16, 2025

In this article, we’ll explore the most effective HCP targeting strategies shaping pharma marketing in 2025—from data segmentation and digital tools to content personalization and compliance. In 2025, HCP targeting helps brands focus their resources on high-value providers—those most likely to prescribe, influence peers, or educate patients.

HIPAA 52

HIPAA Communication Patient Care FDA 52

The FDA Law Blog

JUNE 18, 2025

Livornese — After teasing a new rapid review pilot program for the past few weeks, on June 17, 2025, FDA officially announced the Commissioner’s National Priority Voucher (“CNPV”) program to expedite new drug and biologic (but not device or drug-device combination product) reviews. Tobolowsky & Michelle L. Butler & Deborah L.

FDA 59

FDA Communication Labelling 59

Pharma Marketing Network

APRIL 21, 2025

But are these campaigns truly worth the investment in 2025’s competitive and compliance-heavy landscape? With increasing pressure from regulatory bodies and rising media costs, pharma marketers are rediscovering the power of personalized communication. However, in 2025, the digital transformation continues to accelerate.

HIPAA 52

HIPAA Communication FDA 52

Drug Topics

JUNE 23, 2025

Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.

Community Pharmacies 247

Community Pharmacies Specialty Pharmacies Compounding Independent Pharmacies 247

Pharma Marketing Network

APRIL 18, 2025

As we dive deeper into 2025, the convergence of digital technology, patient-centric strategies, and precision targeting is redefining how pharma brands communicate with both healthcare professionals and patients. Conclusion 2025 is proving to be a landmark year in the evolution of healthcare marketing.

Communication 52

Communication FDA 52

Pharma Marketing Network

JUNE 15, 2025

Whether you’re a seasoned brand manager or a medical affairs communicator, chances are you’ve encountered the Network’s industry-shaping thought leadership or practical tools. Let’s explore what it is, what it offers, and why it matters more than ever in 2025. How does PMN stay current with FDA regulations?

Communication 52

Communication FDA 52

Pharmaceutical Technology

JUNE 6, 2025

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. We are going to make this country the hub of biotechnology innovation,” RFK Jr said during a US Food and Drug Administration (FDA) roundtable on cell and gene therapy on 5 June.

Communication 81

Communication Hospitals Insurance FDA 81

Pharma Marketing Network

JANUARY 7, 2025

In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. In 2025, digital channels dominate marketing strategies as companies shift from traditional campaigns to online platforms. Lets dive into the trends shaping the industry and how you can use them to craft winning strategies.

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharmaceutical Technology

JUNE 12, 2025

Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The pact is a significant moment for Novo Nordisk, pouring significant resources into research that is not centred around incretins. Struggles at the drugmaker culminated in long-time CEO Lars Fruergaard Jørgensen stepping down in May 2025.

Compounding 59

Compounding Communication Hospitals Packaging 59

The FDA Law Blog

MAY 14, 2025

Schwartz In early April, Cellares became the first company to announce receipt of an Advanced Manufacturing Technology (AMT) designation from FDA. 356l), directed FDA to establish the AMT Designation Pilot Program. The law directed FDA to issue guidance regarding the implementation of the program, which was finalized in December 2024.

FDA 59

FDA Communication 59

Pharma Marketing Network

JUNE 16, 2025

As we move deeper into 2025, brands are navigating a rapidly transforming landscape. These communications take into account a provider’s specialty, prescribing patterns, and even digital behavior. Yes, when properly vetted and compliant with FDA regulations. Pharmaceutical advertising has always been complex.

Communication 52

Communication FDA 52

Pharma Marketing Network

MAY 23, 2025

In 2025, artificial intelligence is helping pharmaceutical brands bridge the gap between regulatory precision and meaningful engagement. In 2025, AI is helping medical affairs teams streamline global content review by auto-tagging references, linking claims to citations, and maintaining audit trails.

FDA 64

FDA Documentation Pharmaceutical Companies Pharmaceutical Companies 64

Pharma Marketing Network

JANUARY 29, 2025

In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. For patients, omnichannel marketing is about seamless communication. Conclusion The pharmaceutical trends of 2025 are reshaping the future of pharma marketing.

FDA 52

FDA Communication 52

The FDA Law Blog

SEPTEMBER 22, 2024

The webinar largely consisted of summarizing the general requirements under Parts 803, 806 and 820.198, which we do not reproduce here ( but see another of our prior blog posts discussing these requirements and their applicable to LDTs in greater detail; you can also find FDA’s slides from the webinar here ).

FDA 64

FDA Labelling Communication 64

Pharmaceutical Technology

JUNE 12, 2025

GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Login Registration is disabled.

Communication 52

Communication Hospitals Packaging Insurance 52

PharmTech

JUNE 10, 2025

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.

Vaccines 85

Vaccines Dosage Packaging Immunization 85

Pharmaceutical Technology

JUNE 17, 2025

Manasi Vaidya June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook A panel at the 2025 BIO International Convention discuss the state of the European biotech funding ecosystem. Give your business an edge with our leading industry insights.

Communication 59

Communication Hospitals Packaging Documentation 59

Pharmaceutical Technology

JUNE 19, 2025

June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025. The company is preparing to launch the healthy volunteer segment of a Phase I trial of the therapy in the second half of 2025.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 17, 2025

Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JUNE 25, 2025

Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook CDK2 play a key role in tumour growth, with its dysregulation in cancer leading to uncontrolled cell proliferation via cell cycle progression. Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JUNE 24, 2025

Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Compounded drugs are custom-made and unbranded medications that contain the same active ingredient as a marketed drug.

Compounding 52

Compounding Packaging Communication FDA 52

Pharma Marketing Network

APRIL 10, 2025

Similarly, healthcare providers expect personalized, timely communications that complement their clinical priorities. Ad copy and landing pages must include ISI (Important Safety Information), follow FDA and PhRMA guidelines, and offer fair balance when promoting branded products. Compliance remains essential in paid campaigns.

HIPAA 52

HIPAA Communication FDA 52

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will be used to advance Mosanna’s nasal spray for obstructive sleep apnoea. Can pharma tariffs “Make America Manufacture Again”? Credit: Pixel-Shot/Shutterstock. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Insurance 52